comparemela.com

"Post the emergency use authorisation, now we will work closely with the regulatory authorities to work on the pricing and modality of delivery of the doses of our vaccine. In next one or two weeks we will have better clarity on the pricing," Zydus Group Managing Director Sharvil Patel said in a virtual press conference.

Related Keywords

India ,Russia ,Russian ,Zydus Cadila ,Narendra Modi ,Pankajr Patel ,Sharvil Patel ,Zydus Group ,Serum Institute Of India Covishield ,Group Managing Director Sharvil Patel ,Prime Minister Narendra Modi ,Serum Institute ,Bharat Biotech ,Healthcare Chairman Pankajr Patel ,Cadila Healthcare ,Zydus Group Md Drug ,Covid 19 Vaccine ,Plasmid Dna Vaccine ,Pandemic ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.